CORPORATE OVERVIEW

• COLOMBIA• A LEADER COMPANY HAS BORN

WHO WE ARE We are a dynamic and efficient company which expertise is based on a

knowledgeable and resourceful team that works locally as well asinternationally.

Our company´s mission is to bring to our market, new advances andtechnologies which represent evolution and new hopes for the community ofpatients and for the pharmaceutical market .

OUR GROUP OF ENTERPRISES

HOMOS MEDICAL LABORATORY : Strategicpartner in defence of the label. Representation anddistribution of oncology, HIV and hematologicproducts.

VHICORP LABORATORIES: Brokerpharmacist. Strategic partner in support of yourdevelopment and growth. Representation anddistribution of critical care medicines andspecialised products for hospitals.

CAFI IPS: Pharmaceutical Basic Healthcare Centre where HIV patients receive primary aid.

BIOCORP: Natural alternative to your health. Free medicine prescription (OTC)

COMPANY PROFILE

GIDEON GROUP was founded as a result of the demandof our own set of costumers.

It was created because of the need to consolidate a groupof companies which goal is to provide special attention toour costumers and to the entire pharmaceutical marketwith high standards and quality products and services.

GIDEON GROUP is a group of companies which has beenin the market for over eight years.

Today we have transformed our model of business withinthe group reflecting on the demand and the best target ofpotential costumers.

The integration of these businesses pretends to aid andassist the different needs of our clients such ashemophilia, HIV, oncology, orphan drugs, metabolicdiseases, among others.

OUR HOLDING

Regulatory affairs support

Pharmacovigilance Marketing

management Marketing research Promotional

activities Medical Direction Call reps force in

main cities

Sales to institutions and drugstores

Supply drugs and medical devices to HMO´s patients

Supply and distribute products to patient in ICU

Supply products to private patients

Home delivery program

Attention and Integral treatment

Patient Home Care Management Disease

supported by the program

CRM program to follow up patients in: Dosage Frequency Refills

Importer Market Research Market

development Owner of

Licensing and Brands Projects

CORPORATE VALUES

CONTINUE GROWING

QUALITY

INNOVATION

CREATIVITY

COMMUNITY SERVICE

EFFICIENCY

CONFIDENCE/

TRUST

HOLDING TURN OVER

(*)Established 2006

Capital 100 % Colombian

Turn Over $ Usd 1.000.000

Market Share 1,2 Values 2,3 % Units (I.M.S. ) Distribution

Channels

Sales Mix 80 % Market & distribution Local products

20 % Own Operation

Employees 11 Administrative , 23 Sales and Line Force

HOLDING SALES EVOLUTION

0

500000

1000000

1500000

2000000

2500000

3000000

2006 2007 2008 2009

HOMOS MEDICAL

VIHCORP

CAFI IPS

US DOLLARS

OUR LINES OF THERAPIES

PARENTERAL NUTRITION, NUTRITION ENTERAL AND BIOLOGICAL LINE

CRITICAL CARE

ONCO- VIH LINE PRODUCTS

TRANSPLANTS AND HORMONAL LINE

MARKET DISTRIBUTION CAPABILITY

Distribution Channel

Main sales approach

Accounts Number

Market coverage Number of annual invoices served

Direct Sales IPS

Specialist Pharmacy

162 100% Oncology - arv-blood.74% distributors hospital

4,282

Distributors Purchase manager

195 •95% of dealers 2,873

Hospitals Tender 18 •100% of high complexity hospitals

•10% of level 1-2

446

Direct Sales EPS

Tender Recruitment

4 35% of patients with catastrophic diseases

129

MARKETING & DIRECTION STAFF

BOARD OF DIRECTORS

B.DEVELOPMENT DIRECTOR

MEDICAL HOLDING DIRECTOR

SALES NATIONAL MANAGER

ADMINISTRATIVE MANAGER

KEY ACCOUNT ONCO- ARV LINE

KEY ACCOUNT HOSPITAL

KEY ACCOUNT CRITICAL CARE

TENDER´S REP. K.A.

REPS. TEAM HOMOS MEDICAL•Bogota(2)•Cali(1)•Medellin(1)•Costa (2)

REPS. TEA VHICORP LAB.

•Bogota(2)•Cali(2)•Medellin(2)•Costa (4)

REPS. TEA VHICORP LAB.

•Bogota(2)•Cali(1)•Medellin(2)•Costa (2)

MARKETING COORDINATOR

STRATEGIC PARTNER IN DEFENCE OF THE LABEL.